SCHEMBL9709717

SCHEMBL9709717

COC(=O)CCC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)CCOc1cccnc1

nearest known ligand 0.84

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 20/20 0.84
TBXA2R P21731 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9732694 0.93 TBXAS1 (0.80) TBXAS1TBXA2R
SCHEMBL9709498 0.91 TBXAS1 (1.00) TBXAS1TBXA2R
SCHEMBL9709493 0.91 TBXAS1 (1.00) TBXAS1TBXA2R
SCHEMBL9709541 0.91 TBXAS1 (1.00) TBXAS1TBXA2R
SCHEMBL9732801 0.86 TBXAS1 (0.82) TBXAS1TBXA2R
SCHEMBL9709586 0.85 TBXAS1 (0.62) TBXAS1TBXA2R
SCHEMBL9732871 0.81 TBXAS1 (0.81) TBXAS1TBXA2R
SCHEMBL9732867 0.81 TBXAS1 (0.81) TBXAS1TBXA2R
SCHEMBL9709574 0.81 TBXAS1 (0.54) TBXAS1TBXA2R
SCHEMBL9709594 0.80 TBXAS1 (0.54) TBXAS1TBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5153214-A Treating cardiovascular disorders CIBA-GEIGY CORPORATION (US) 1992-10-06 US disclosed
EP-0493324-A1 Certain (arylsulfonamido- and pyridyl- or imidazolyl-)-substituted carboxylic acids and derivatives thereof CIBA-GEIGY AG (CH) 1992-07-01 EP disclosed
US-5025025-A Cardiovascular disorders CIBA-GEIGY CORPORATION (US) 1991-06-18 US disclosed
EP-0405391-A1 Certain (arylsulfonamido- and pyridyl- or imidazolyl-)-substituted carboxylic acids and derivatives thereof CIBA-GEIGY AG (CH) 1991-01-02 EP disclosed